메뉴 건너뛰기




Volumn 11, Issue 4, 2012, Pages 271-276

A comparison of the impact of isotope ( 125I vs. 103Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer

Author keywords

Brachytherapy; External beam radiation therapy; Iodine 125; Palladium 103; Prostate cancer

Indexed keywords

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

EID: 84862541928     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.11.002     Document Type: Article
Times cited : (20)

References (22)
  • 1
    • 0036680314 scopus 로고    scopus 로고
    • Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial
    • Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53:1097-1105.
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , pp. 1097-1105
    • Pollack, A.1    Zagars, G.K.2    Starkschall, G.3
  • 2
    • 24644443217 scopus 로고    scopus 로고
    • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial
    • Zietman A.L., DeSilvio M.L., Koper P.C., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005, 294:1233-1239.
    • (2005) JAMA , vol.294 , pp. 1233-1239
    • Zietman, A.L.1    DeSilvio, M.L.2    Koper, P.C.3
  • 3
    • 33646462895 scopus 로고    scopus 로고
    • Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
    • Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24:1990-1996.
    • (2006) J Clin Oncol , vol.24 , pp. 1990-1996
    • Peeters, S.T.1    Heemsbergen, W.D.2    Koper, P.C.3
  • 4
    • 34249316816 scopus 로고    scopus 로고
    • Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial
    • Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007, 8:475-487.
    • (2007) Lancet Oncol , vol.8 , pp. 475-487
    • Dearnaley, D.P.1    Sydes, M.R.2    Graham, J.D.3
  • 5
    • 33846203312 scopus 로고    scopus 로고
    • Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
    • Zelefsky M.J., Kuban D.A., Levy D.B., et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007, 67:327-333.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 327-333
    • Zelefsky, M.J.1    Kuban, D.A.2    Levy, D.B.3
  • 6
    • 33748294108 scopus 로고    scopus 로고
    • High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study
    • Vargas C.E., Martinez A.A., Boike T.P., et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study. Int J Radiat Oncol Biol Phys 2006, 66:416-423.
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , pp. 416-423
    • Vargas, C.E.1    Martinez, A.A.2    Boike, T.P.3
  • 7
    • 14544289582 scopus 로고    scopus 로고
    • Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
    • Sathya J.R., Davis I.R., Julian J.A., et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 2005, 23:1192-1199.
    • (2005) J Clin Oncol , vol.23 , pp. 1192-1199
    • Sathya, J.R.1    Davis, I.R.2    Julian, J.A.3
  • 8
    • 4644354413 scopus 로고    scopus 로고
    • Iodine 125 versus palladium 103 implants for prostate cancer: Clinical outcomes and complications
    • Peschel R.E., Colberg J.W., Chen Z., et al. Iodine 125 versus palladium 103 implants for prostate cancer: Clinical outcomes and complications. Cancer J 2004, 10:170-174.
    • (2004) Cancer J , vol.10 , pp. 170-174
    • Peschel, R.E.1    Colberg, J.W.2    Chen, Z.3
  • 9
    • 28444485693 scopus 로고    scopus 로고
    • I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial
    • Herstein A., Wallner K., Merrick G., et al. I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial. Cancer J 2005, 11:385-389.
    • (2005) Cancer J , vol.11 , pp. 385-389
    • Herstein, A.1    Wallner, K.2    Merrick, G.3
  • 10
    • 0344395011 scopus 로고    scopus 로고
    • 125I versus 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial
    • Wallner K., Merrick G., True L., et al. 125I versus 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 2003, 57:1297-1303.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 1297-1303
    • Wallner, K.1    Merrick, G.2    True, L.3
  • 11
    • 33845627723 scopus 로고    scopus 로고
    • Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer
    • Zelefsky M.J., Yamada Y., Cohen G.N., et al. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2007, 67:65-70.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 65-70
    • Zelefsky, M.J.1    Yamada, Y.2    Cohen, G.N.3
  • 12
    • 30544440136 scopus 로고    scopus 로고
    • Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results
    • Stock R.G., Stone N.N., Cesaretti J.A., et al. Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys 2006, 64:525-533.
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 525-533
    • Stock, R.G.1    Stone, N.N.2    Cesaretti, J.A.3
  • 13
    • 33745184874 scopus 로고    scopus 로고
    • Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
    • Roach M., Hanks G., Thames H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006, 65:965-974.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , pp. 965-974
    • Roach, M.1    Hanks, G.2    Thames, H.3
  • 14
    • 0029065422 scopus 로고
    • Advances in benign prostatic hyperplasia. The developmental and clinical utility of symptom scores
    • Barry M.J., O'Leary M.P. Advances in benign prostatic hyperplasia. The developmental and clinical utility of symptom scores. Urol Clin North Am 1995, 22:299-307.
    • (1995) Urol Clin North Am , vol.22 , pp. 299-307
    • Barry, M.J.1    O'Leary, M.P.2
  • 15
    • 0032323716 scopus 로고    scopus 로고
    • Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate
    • Terk M.D., Stock R.G., Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998, 160:1379-1382.
    • (1998) J Urol , vol.160 , pp. 1379-1382
    • Terk, M.D.1    Stock, R.G.2    Stone, N.N.3
  • 16
    • 0036499149 scopus 로고    scopus 로고
    • Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study
    • Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys 2002, 52:712-719.
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 712-719
    • Locke, J.1    Ellis, W.2    Wallner, K.3
  • 17
    • 0034255980 scopus 로고    scopus 로고
    • Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer
    • Gelblum D.Y., Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2000, 48:119-124.
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , pp. 119-124
    • Gelblum, D.Y.1    Potters, L.2
  • 18
    • 0036570302 scopus 로고    scopus 로고
    • Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy
    • Kang S.K., Chou R.H., Dodge R.K., et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002, 53:99-103.
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , pp. 99-103
    • Kang, S.K.1    Chou, R.H.2    Dodge, R.K.3
  • 19
    • 0042889278 scopus 로고    scopus 로고
    • Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy
    • Albert M., Tempany C.M., Schultz D., et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 2003, 98:949-954.
    • (2003) Cancer , vol.98 , pp. 949-954
    • Albert, M.1    Tempany, C.M.2    Schultz, D.3
  • 20
    • 70349560041 scopus 로고    scopus 로고
    • Erectile function durability following permanent prostate brachytherapy
    • Taira A.V., Merrick G.S., Galbreath R.W., et al. Erectile function durability following permanent prostate brachytherapy. Int J Oncol Biol Phys 2009, 75:639-648.
    • (2009) Int J Oncol Biol Phys , vol.75 , pp. 639-648
    • Taira, A.V.1    Merrick, G.S.2    Galbreath, R.W.3
  • 21
    • 33845599085 scopus 로고    scopus 로고
    • 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience
    • Sylvester J.E., Grimm P.D., Blasko J.C., et al. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int J Radiat Oncol Biol Phys 2007, 67:57-64.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 57-64
    • Sylvester, J.E.1    Grimm, P.D.2    Blasko, J.C.3
  • 22
    • 77956841520 scopus 로고    scopus 로고
    • Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy
    • [Epub ahead of print]
    • Dattoli M., Wallner K., True L., et al. Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy. J Oncol 2010, [Epub ahead of print].
    • (2010) J Oncol
    • Dattoli, M.1    Wallner, K.2    True, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.